Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Scott Bortman

Internal Medicine North Easton, MA Medical Doctor

NPI 1518940568 CMS profile 205129

15 Roche Bros Way, Suite 110, North Easton, MA 02356

Open in the dashboard

General payments

$30,716

186 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, Scott Bortman of North Easton, MA is reported in the CMS Open Payments database as having received $30,716 across 186 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $399 20
2019 General $30,317 166

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Bortman
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Scott Bortman were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Scott Bortman Internal Medicine median Middle half National median
2019 $30,317 $159 $48–$570 $163
2020 $399 $119 $33–$402 $114
2021 $0 $135 $37–$521 $132
2022 $0 $141 $42–$496 $149
2023 $0 $149 $45–$519 $160
2024 $0 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharmaceuticals Corporation $11,077 71 payments
  2. Sanofi-Aventis U.S. LLC $10,414 13 payments
  3. Boston Scientific Corporation $3,381 17 payments
  4. Janssen Pharmaceuticals, Inc $3,299 16 payments
  5. Regeneron Healthcare Solutions, Inc. $1,455 13 payments
  6. Amgen Inc. $204 9 payments
  7. AstraZeneca Pharmaceuticals LP $191 12 payments
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $150 9 payments
  9. E.R. Squibb & Sons, L.L.C. $98 5 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $82 4 payments
  11. Other $365 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,007 10 payments
  2. Food and Beverage $2,638 170 payments
  3. Travel and Lodging $1,072 6 payments
Products named General payments · program years 2019–2020
  1. ENTRESTO $11,077 71 payments
  2. PRALUENT Cardiovascular $10,385 11 payments
  3. WATCHMAN $3,381 17 payments
  4. XARELTO $3,299 16 payments
  5. PRALUENT Cardiovascular And Metabolism $1,455 13 payments
  6. Repatha $204 9 payments
  7. LifeVest $150 9 payments
  8. BRILINTA $143 9 payments
  9. ELIQUIS $98 5 payments
  10. JARDIANCE $82 4 payments
  11. Other $574 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record